Portal:Treatments/Selected article/3

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 18:10, July 20, 2021 by Notjusttired (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

[[File:Light2011-geneexpression-figure3.jpg|thumb|upright=0.5|Ampligen Ampligen™︎®︎ (generic name: rintatolimod) is a drug used for severe ME/CFS in Argentina and unlicensed but available under early access or compassionate care programs in the United States, European Union and Japan.

Retrieved from "https://me-pedia.org/w/index.php?title=Portal:Treatments/Selected_article/3&oldid=92650"